Mustang Bio Announces Orphan Drug Designation for MB-107 for the Treatment of X-linked Severe Combined Immunodeficiency in Newly Diagnosed Infants
Stock Information for Fortress Biotech Inc.
Loading
Please wait while we load your information from QuoteMedia.